The present application relates to novel heteroaryl-substituted imidazo[1,2-a]pyridines, to a method for producing same, to the use thereof alone or in combinations for treating and/or preventing diseases, and to the use thereof for producing medicinal drugs for treating and/or preventing diseases, in particular for treating and/or preventing cardiovascular diseases.